U.S. scientists were able to produce induced pluripotent stem cells with the same characteristics as embryonic stem cells by reprogramming human-skin-derived cells using four regulator genes, confirming similar work reported late last year by other scientists. The technique could provide a source for immune-compatible cells that can be used in tissue engineering and transplantation, scientists said.

Full Story:

Related Summaries